tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Neurocrine (NBIX)
NASDAQ:NBIX
US Market
NBIX
Neurocrine
RESEARCH TOOLSreports
Advertisement

Neurocrine (NBIX) Stock News & Sentiment

Compare
1,464 Followers
Promising Phase 2 Results and Safety Profile of Osavampator Justify Buy Rating for Neurocrine Biosciences
Premium
Ratings
Promising Phase 2 Results and Safety Profile of Osavampator Justify Buy Rating for Neurocrine Biosciences
7d ago
NBIX
Neurocrine’s Osavampator Shows Promising Phase 2 Results, Boosting Buy Rating and Stock Price Target
Premium
Ratings
Neurocrine’s Osavampator Shows Promising Phase 2 Results, Boosting Buy Rating and Stock Price Target
8d ago
NBIX
Promising Potential of Neurocrine’s Osavampator in Treating Major Depressive Disorder: A Buy Recommendation by Sean Laaman
Premium
Ratings
Promising Potential of Neurocrine’s Osavampator in Treating Major Depressive Disorder: A Buy Recommendation by Sean Laaman
8d ago
NBIX
Neurocrine’s Strong Market Performance and Promising Pipeline Justify Buy Rating
Premium
Ratings
Neurocrine’s Strong Market Performance and Promising Pipeline Justify Buy Rating
2M ago
NBIX
Promising Growth and Strategic Positioning Drive Buy Rating for Neurocrine
Premium
Ratings
Promising Growth and Strategic Positioning Drive Buy Rating for Neurocrine
2M ago
NBIX
Neurocrine Biosciences Advances Schizophrenia Treatment with Phase 3 Study
Premium
Company Announcements
Neurocrine Biosciences Advances Schizophrenia Treatment with Phase 3 Study
2M ago
NBIX
Neurocrine Biosciences Advances Phase 3 Study on Valbenazine for Cerebral Palsy Dyskinesia
Premium
Company Announcements
Neurocrine Biosciences Advances Phase 3 Study on Valbenazine for Cerebral Palsy Dyskinesia
2M ago
NBIX
More NBIX News >

NBIX News on the Web

GRFS or NBIX: Which Is the Better Value Stock Right Now?
Zacks
Neutral
Leerink Partners Remains a Buy on Neurocrine (NBIX)
TipRanks News
Neutral
BMO Capital Sticks to Its Hold Rating for Neurocrine (NBIX)
TipRanks News
Neutral
Neurocrine (NBIX) Receives a Buy from Piper Sandler
TipRanks News
Neutral
Which Is a Better Investment, Neurocrine Biosciences, Inc. or Roivant Sciences Ltd. Stock?
AAII
Neutral
Neurocrine (NBIX) Receives a Buy from RBC Capital
TipRanks News
Neutral
GRFS or NBIX: Which Is the Better Value Stock Right Now?
Zacks
Neutral
Xenon Q2 Loss Wider Than Expected, Pipeline Development in Focus
Zacks
Neutral

News Score - Last 7 Days

Neutral
NBIX
Sector Average
Media Buzz
This Week2 articles
Weekly Average1.5 articles
News Sentiment
This Week50%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NBIX’s Media Buzz Sentiment?
2 articles about NBIX were published this week. In an average week, 1.5 articles are published.
    What is NBIX’s weekly average amount of articles?
    In an average week, 1.5 articles about NBIX are published.
      What is NBIX’s News Sentiment?
      50% of articles about NBIX were positive this week, compared to its sector average of 56%.
        Healthcare Stocks that are Trending in the News
        COLLCollegium Pharmaceutical
        ACADACADIA Pharmaceuticals
        SUPNSupernus Pharmaceuticals
        CDTXCidara Therapeutics
        ADUSAddus Homecare
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing